Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04756869 · ClinicalTrials.gov registry record
Monitoring Health Care Workers at Risk for COVID-19 Using Wearable Sensors and Smartphone Technology
A clinical trial, sponsored by University of Michigan.
- Completed
- Registry status
- 226
- Enrollment target
NCT04756869: Completed study, sponsored by University of Michigan.
NCT04756869 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 226 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04756869 has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 226 participants
- Enrollment target
Study Summary
This prospective study of health care workers utilizes wearable sensors, surveys and symptom logs, and biospecimens in an effort to improve self-monitoring practices for COVID-19 among health care workers and to provide key data for the development of a predictive model for early detection of COVID-19 infection.
Primary Outcome
Feasibility is defined as wearing the Fitbit Watch for at least 8 hours a day, 5 days a week (\~40 hours/week or 160 hours/30 days).
Interventions
- OTHER COVID-19 Monitoring Using Wearable Sensors and Smartphone Technology
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 226 participants |
| Start Date | 2020-04-28 |
| Est. Completion | 2021-01-16 |
What the finished NCT04756869 record still lists
NCT04756869 is an observational study that tracks outcomes without assigning an intervention. The registered 226 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which COVID-19 Monitoring Using Wearable Sensors and Smartphone Technology is the first listed.
NCT04756869 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04756869 about?
NCT04756869 is a clinical study titled "Monitoring Health Care Workers at Risk for COVID-19 Using Wearable Sensors and Smartphone Technology". This prospective study of health care workers utilizes wearable sensors, surveys and symptom logs, and biospecimens in an effort to improve self-monitoring practices for COVID-19 among health care workers and to provide key data for the development of a predictive model for early detection of COVID-...
What is the current status of trial NCT04756869?
This trial is currently completed. The enrollment target is 226 participants. The study started on 2020-04-28. Estimated completion is 2021-01-16.
What interventions are being tested in trial NCT04756869?
The interventions under investigation include: COVID-19 Monitoring Using Wearable Sensors and Smartphone Technology (OTHER).
Who is sponsoring clinical trial NCT04756869?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04419272 · 226 participants · Phase 4
Methylphenidate for the Treatment of Epilepsy-related Cognitive Deficits
- NCT05449002 · 226 participants · NA
Digital Single Session Intervention for Youth Mental Health
- NCT05488054 · 226 participants · NA
Muscle O2 Saturation and Hemoglobin Levels During Rehabilitation From Arthroscopic Surgery
- NCT05924477 · 226 participants · NA
Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI